These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8097617)

  • 21. Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration.
    Foushee JA; Fox LM; Gormley LR; Lineberger MS
    Am J Health Syst Pharm; 2015 Mar; 72(6):483-6. PubMed ID: 25736944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration.
    Bashaw ED; Amantea MA; Minor JR; Gallelli JF
    Am J Hosp Pharm; 1988 Dec; 45(12):2532-3. PubMed ID: 3228107
    [No Abstract]   [Full Text] [Related]  

  • 23. Visual compatibility of enalaprilat with selected intravenous medications during simulated Y-site injection.
    Thompson DF; Allen LV; Stiles ML
    Am J Hosp Pharm; 1990 Nov; 47(11):2530-1. PubMed ID: 2177585
    [No Abstract]   [Full Text] [Related]  

  • 24. Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection.
    Jay GT; Fanikos J; Souney PF
    Am J Hosp Pharm; 1988 Jul; 45(7):1556-7. PubMed ID: 3414721
    [No Abstract]   [Full Text] [Related]  

  • 25. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
    Lor E; Sheybani T; Takagi J
    Am J Hosp Pharm; 1991 Apr; 48(4):744-6. PubMed ID: 2042678
    [No Abstract]   [Full Text] [Related]  

  • 26. Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1993 Nov; 50(11):2359-63. PubMed ID: 8266963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Jun; 45(6):1357-8. PubMed ID: 3414706
    [No Abstract]   [Full Text] [Related]  

  • 28. Seventy-two-hour stability of Taxol in 5% dextrose or 0.9% sodium chloride in Viaflo, Freeflex, Ecoflac and Macoflex N non-PVC bags.
    Pourroy B; Botta C; Solas C; Lacarelle B; Braguer D
    J Clin Pharm Ther; 2005 Oct; 30(5):455-8. PubMed ID: 16164492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical issues: preparation, administration, stability, and compatibility with other medications.
    Goldspiel BR
    Ann Pharmacother; 1994 May; 28(5 Suppl):S23-6. PubMed ID: 7915155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
    Souney PF; Colucci RD; Mariani G; Campbell D
    Am J Hosp Pharm; 1984 Feb; 41(2):323-4. PubMed ID: 6702842
    [No Abstract]   [Full Text] [Related]  

  • 31. Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection.
    Pugh CB; Pabis DJ; Rodriguez C
    Am J Hosp Pharm; 1991 Jan; 48(1):123-5. PubMed ID: 2000871
    [No Abstract]   [Full Text] [Related]  

  • 32. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
    Trissel LA; Zhang Y
    Ann Pharmacother; 2005 Feb; 39(2):280-3. PubMed ID: 15613463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
    Nieves-Cordero AL; Luciw HM; Souney PF
    Am J Hosp Pharm; 1985 May; 42(5):1108-9. PubMed ID: 4003421
    [No Abstract]   [Full Text] [Related]  

  • 34. Visual compatibility of tolazoline hydrochloride with various medications during simulated Y-site injection.
    Marquardt ED
    Am J Hosp Pharm; 1990 Aug; 47(8):1802-3. PubMed ID: 2389789
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparison of the pharmacokinetics and safety of a paclitaxel injection NK and Taxol injection in breast cancer patients].
    Sagara Y; Rai Y; Sagara Y; Matsuyama Y; Baba S; Tamada S; Sagara Y; Ando M
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):247-50. PubMed ID: 19223739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual compatibility of gallium nitrate with selected drugs during simulated Y-site injection.
    Lober CA; Dollard PA
    Am J Hosp Pharm; 1993 Jun; 50(6):1208-10. PubMed ID: 8517464
    [No Abstract]   [Full Text] [Related]  

  • 37. Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
    Percy LA; Rho JP
    Am J Hosp Pharm; 1993 Apr; 50(4):715-6. PubMed ID: 8470693
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mixtures of infusion solutions and drugs. Compatibility and incompatibility].
    Pecar A; Dirks B
    Anaesthesist; 1995 Nov; 44(11):793-803. PubMed ID: 8678272
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
    Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
    Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel diluent and the case of the slippery spike.
    Martin M; Bepko R
    Am J Hosp Pharm; 1994 Dec; 51(24):3078, 3080. PubMed ID: 7856630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.